Genetic testing may be used to identify BPH patients with increased risk of prostate cancer
(European Association of Urology) Patients with benign prostatic hyperplasia carrying prostate cancer (PCa) a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented yesterday at the 28th Annual EAU Congress in Milan.
Source: EurekAlert! - Social and Behavioral Science - Category: Global & Universal Source Type: news
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Genetics | International Medicine & Public Health | Politics | Prostate Cancer | Science | Study | Urology & Nephrology